Table 1.
Lane no. | Position, bp | Nucleotide change | Cell type | Age, years | Mutant fraction*, % | SD†, % |
---|---|---|---|---|---|---|
1 | 73 | G→A | Buccal | 76 | 39 | 5 |
2 | 189 | A→G | Myocyte | 109 | 71 | 8 |
3 | 189 | A→G | Myocyte | 109 | 58 | 5 |
4 | 214 | A→G | Buccal | 85 | 60 | 14 |
5 | 251 | G→C | Buccal | 93 | 98 | 2 |
6 | 252 | T→C | Buccal | 85 | 69 | 23 |
7 | 303–310 | ins C | Buccal | 5 | 30 | 11 |
8 | 303–310 | ins C | Buccal | 76 | 61 | 3 |
9 | 303–310 | ins C | Buccal | 76 | 28 | 3 |
10 | 303–310 | ins 1,2C | Buccal | 76 | 83 | 4 |
11 | 303–310 | ins 1,2C | Buccal | 76 | 43 | 4 |
12 | 303–309 | ins 2,3,4C | Buccal | 85 | 100 | 0 |
13 | 303–309 | ins C | Buccal | 85 | 43 | 15 |
14 | 303–310 | del C | Buccal | 93 | 95 | 7 |
15 | 303–310 | ins C | Buccal | 93 | 29 | 1 |
16 | 303–310 | del C | Buccal | 93 | 88 | 1 |
17 | 303–310 | ins 1,2C | Buccal | 93 | 53 | 9 |
18 | 303–310 | ins 1,2,3C | Buccal | 93 | 94 | 1 |
19 | 303–310 | del C | Myocyte | 104 | 28 | 3 |
20 | 16,028 | T→C | Myocyte | 51 | 65 | 7 |
21 | 16,029 | T→C | Myocyte | 109 | 53 | 4 |
22 | 16,029 | T→C | Myocyte | 109 | 57 | 4 |
23 | 16,033 | G→A | Myocyte | 109 | 50 | 14 |
24 | 16,034 | G→A | Myocyte | 109 | 25 | 1 |
25 | 16,035 | G→A | Myocyte | 104 | 58 | 4 |
26 | 16,035 | G→A | Myocyte | 109 | 100 | 0 |
27 | 16,036 | G→A | Myocyte | 104 | 73 | 10 |
28 | 16,036 | G→A | Myocyte | 109 | 91 | 8 |
29 | 16,049 | G→A | Myocyte | 109 | 80 | 8 |
30 | 16,052–3 | del C | Myocyte | 104 | 78 | 11 |
31 | 16,054 | A→G | Myocyte | 51 | 65 | 1 |
Note that generally there was one mutation per cell except for the four cells in which there were two mutations (mutations in lanes 1 and 10, 5 and 15, 2 and 21, and 3 and 29).
The averages are of at least two independent measurements from two independent PCR amplifications from the same cell.
Formal standard deviations are given to illustrate the extent of reproducibility of the data.